Abstract
Introduction: This study was conducted to find out whether blood transfusion was an independent risk factor for mortality and wound infection after hip fracture surgery.
Materials and Methods: A retrospective cohort study analysed prospectively collected data for 3571 hip fracture patients undergoing surgery over the last 15 years in one institution. Out of these 1068 patients underwent blood transfusion.
Results: There were no significant differences in the mortality values at 30, 120 and 365 days and in the rates of infection (superficial and deep) in the two groups(transfused and non-transfused).
Conclusion: Blood transfusion does not significantly increase mortality or infection following hip fracture surgery.
Theses abstracts were prepared by Professor Roger Lemaire. Correspondence should be addressed to EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.
